4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-26-000055
Chief Technology Officer sold 2,754 shares at $29.62 ($81,573)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stout Jay S Chief Technology Officer | 2026-04-23 | Sale | −2,754 | $29.62 | $81,573 | 251,685 | D |
| Open-market sales · 2,754 sh · avg $29.62 · $81,573 | |||||||
Loading xslF345X06/wk-form4_1777061153.xml…